Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1 Plasma cell 1 Other solid neoplasm 1 Breast 1

Conditions

Multiple Myeloma 1

Interventions

Dexamethasone 393 Bortezomib 246 Lenalidomide 222 Cyclophosphamide 184 Melphalan 168 Calcium Dobesilate 119 Peripheral Blood Stem Cell Transplantation 94 fludarabine phosphate 89 Thalidomide 82 Filgrastim 74 carfilzomib 70 pomalidomide 68 Granulocyte Colony-Stimulating Factor 63 Busulfan 63 Mycophenolic Acid 61 daratumumab 58 Whole-Body Irradiation 57 ixazomib 54 fludarabine 52 Tacrolimus 52 Prednisone 51 Cyclosporine 50 Antilymphocyte Serum 35 dexamethasone acetate 32 plerixafor 30 Etoposide 30 Methotrexate 29 Radiotherapy 28 dexamethasone 21-phosphate 27 Doxorubicin 26

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Safety × Plasma cell × Clear all

NCT02786511 2020-01-22

Longterm Follow-up of Subjects Treated With bb2121

Celgene

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡